Výsledky vyhledávání - "Dileep Bhagwat"

Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)

Autor: Penney Cowan, Sharon Hertz, Karin S. Coyne, Dileep Bhagwat, Dennis C. Turk, Robert H. Dworkin, Dennis Everton, John T. Farrar, Sarah Peirce-Sandner, Ronald Melzack, Bob A. Rappaport, Mitchell B. Max, Laurie B. Burke, Gale Harding, Dennis A. Revicki

Publikováno v: Pain. 144:35-42

The objective of the present research was to develop a single measure of the major symptoms of both neuropathic and non-neuropathic pain that can be used in studies of epidemiology, natural history, pathophysiologic mechanisms, and treatment response

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22f73f44371eabc752976d197d86660
https://doi.org/10.1016/j.pain.2009.02.007

Zobrazit plný text záznamu

Development of dissolution tests for oral extended-release products

Autor: Dileep Bhagwat, Ellen D. Jorgensen

Publikováno v: Pharmaceutical Science & Technology Today. 1:128-135

Dissolution testing is well established in pharmaceutical compendia as a means of assessing finished product quality. Oral extended-release products present unique challenges in the development of dissolution test methods for their characterization.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::919692d35e71c479c6bb06b9041ea99d
https://doi.org/10.1016/s1461-5347(98)00029-7

Zobrazit plný text záznamu

Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission

Autor: Marc Buyse, Kristoffer Hellstrand, John K. Whisnant, Dileep Bhagwat, Mats Brune, Stephane E Allard, Pierre Squifflet, Jacob M. Rowe

Publikováno v: Blood. 112:1948-1948

Background: Data from a randomized multinational trial of 320 adults with AML demonstrated that maintenance therapy with 3-week cycles of histamine dihydrochloride plus low-dose interleukin-2 (HDC/IL-2) for up to 18 months significantly improved leuk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c70f514e39d8e62d3bceb3d586fe27ef
https://doi.org/10.1182/blood.v112.11.1948.1948

Zobrazit plný text záznamu

Impact on Quality of Life of Postconsolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in Acute Myelogenous Leukemia

Autor: Jeff Szer, Mats Brune, Jacob M. Rowe, Elisabeth Wallhult, Kristoffer Hellstrand, John K. Whisnant, Bo Nilsson, Dileep Bhagwat

Publikováno v: Blood. 110:4381-4381

PURPOSE: To assess the impact on Quality of Life (QoL) of postconsolidation immunotherapy with histamine dihydrochloride (HDC) in combination with interleukin-2 (IL-2) in acute myelogenous leukemia (AML). PATIENTS & METHODS: A multi-national randomiz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e65c2021e116f9e32d7120bff67f2c4
https://doi.org/10.1182/blood.v110.11.4381.4381

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání